Provided by Tiger Trade Technology Pte. Ltd.

CARDIO DIAGNOSTICS HOLDINGS INC C/WTS (01/12/2026) TO PUR COM

0.0167
-0.0005-2.91%
Volume:618.00
Turnover:10.11
Market Cap:29.44K
PE:0.00
High:0.0167
Open:0.0162
Low:0.0162
Close:0.0172
52wk High:0.0850
52wk Low:0.0100
Shares:1.76M
Float Shares:1.76M
Volume Ratio:0.32
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0691
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
CARDIO DIAGNOSTICS HOLDINGS INC C/WTS (01/12/2026) TO PUR COM
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.